Nasal continuous positive airway pressure and outcomes in preterm infants: A retrospective analysis

Gustavo Pelligra, Mohamed A. Abdellatif, Shoo K. Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: The aim of the present retrospective study was to describe the use of nasal continuous positive airway pressure (NCPAP) and the prevalence of bronchopulmonary dysplasia (BPD). STUDY DESIGN: Data from 1526 neonates with gestational age less than 32 weeks, admitted to Children's and Women's Health Centre of British Columbia (Vancouver, British Columbia) between period 1 (1996 to 2000) and period 2 (2000 to 2004) were analyzed. The use of respiratory therapies and outcomes were retrospectively compared before and after the introduction of a NCPAP approach to respiratory support. RESULTS: A significant increase in the use of NCPAP was noted between periods 1 and 2 (60% versus 71%), as well as a significant reduction in the use of surfactant (50% versus 41%), postnatal steroids (30% versus 10%) and the need for mechanical ventilation (77% versus 64%). In period 2, there was a significant reduction in the prevalence of BPD at 28 days (33% versus 26%), higher prevalence of severe retinopathy of prematurity (3% versus 6%) and less periventricular leukomalacia (4% versus 2%). CONCLUSIONS: A significant increase in the use of NCPAP therapy in the neonatal unit has been associated with a decrease in the use of more invasive therapies. The incidence of BPD has decreased if defined as need for supplemental oxygen at 28 days of age, but not when the 36 weeks' postconceptional age criterion was used. NCPAP therapy may decrease the use of more invasive therapies and may improve respiratory outcomes. The impact of this intervention on nonrespiratory outcomes warrants further investigation.

Original languageEnglish
Pages (from-to)99-103
Number of pages5
JournalPaediatrics and Child Health
Volume13
Issue number2
Publication statusPublished - Feb 2008

Fingerprint

Continuous Positive Airway Pressure
Premature Infants
Bronchopulmonary Dysplasia
British Columbia
Periventricular Leukomalacia
Respiratory Therapy
Retinopathy of Prematurity
Women's Health
Therapeutics
Artificial Respiration
Surface-Active Agents
Gestational Age
Retrospective Studies
Steroids
Newborn Infant
Oxygen
Incidence

Keywords

  • Bronchopulmonary dysplasia
  • CPAP
  • Neonatology
  • Premature infants
  • Retinopathy of prematurity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Nasal continuous positive airway pressure and outcomes in preterm infants : A retrospective analysis. / Pelligra, Gustavo; Abdellatif, Mohamed A.; Lee, Shoo K.

In: Paediatrics and Child Health, Vol. 13, No. 2, 02.2008, p. 99-103.

Research output: Contribution to journalArticle

@article{00ac790f3c204f85b01060b9c5490017,
title = "Nasal continuous positive airway pressure and outcomes in preterm infants: A retrospective analysis",
abstract = "OBJECTIVE: The aim of the present retrospective study was to describe the use of nasal continuous positive airway pressure (NCPAP) and the prevalence of bronchopulmonary dysplasia (BPD). STUDY DESIGN: Data from 1526 neonates with gestational age less than 32 weeks, admitted to Children's and Women's Health Centre of British Columbia (Vancouver, British Columbia) between period 1 (1996 to 2000) and period 2 (2000 to 2004) were analyzed. The use of respiratory therapies and outcomes were retrospectively compared before and after the introduction of a NCPAP approach to respiratory support. RESULTS: A significant increase in the use of NCPAP was noted between periods 1 and 2 (60{\%} versus 71{\%}), as well as a significant reduction in the use of surfactant (50{\%} versus 41{\%}), postnatal steroids (30{\%} versus 10{\%}) and the need for mechanical ventilation (77{\%} versus 64{\%}). In period 2, there was a significant reduction in the prevalence of BPD at 28 days (33{\%} versus 26{\%}), higher prevalence of severe retinopathy of prematurity (3{\%} versus 6{\%}) and less periventricular leukomalacia (4{\%} versus 2{\%}). CONCLUSIONS: A significant increase in the use of NCPAP therapy in the neonatal unit has been associated with a decrease in the use of more invasive therapies. The incidence of BPD has decreased if defined as need for supplemental oxygen at 28 days of age, but not when the 36 weeks' postconceptional age criterion was used. NCPAP therapy may decrease the use of more invasive therapies and may improve respiratory outcomes. The impact of this intervention on nonrespiratory outcomes warrants further investigation.",
keywords = "Bronchopulmonary dysplasia, CPAP, Neonatology, Premature infants, Retinopathy of prematurity",
author = "Gustavo Pelligra and Abdellatif, {Mohamed A.} and Lee, {Shoo K.}",
year = "2008",
month = "2",
language = "English",
volume = "13",
pages = "99--103",
journal = "Paediatrics and Child Health",
issn = "1205-7088",
publisher = "Pulsus Group Inc.",
number = "2",

}

TY - JOUR

T1 - Nasal continuous positive airway pressure and outcomes in preterm infants

T2 - A retrospective analysis

AU - Pelligra, Gustavo

AU - Abdellatif, Mohamed A.

AU - Lee, Shoo K.

PY - 2008/2

Y1 - 2008/2

N2 - OBJECTIVE: The aim of the present retrospective study was to describe the use of nasal continuous positive airway pressure (NCPAP) and the prevalence of bronchopulmonary dysplasia (BPD). STUDY DESIGN: Data from 1526 neonates with gestational age less than 32 weeks, admitted to Children's and Women's Health Centre of British Columbia (Vancouver, British Columbia) between period 1 (1996 to 2000) and period 2 (2000 to 2004) were analyzed. The use of respiratory therapies and outcomes were retrospectively compared before and after the introduction of a NCPAP approach to respiratory support. RESULTS: A significant increase in the use of NCPAP was noted between periods 1 and 2 (60% versus 71%), as well as a significant reduction in the use of surfactant (50% versus 41%), postnatal steroids (30% versus 10%) and the need for mechanical ventilation (77% versus 64%). In period 2, there was a significant reduction in the prevalence of BPD at 28 days (33% versus 26%), higher prevalence of severe retinopathy of prematurity (3% versus 6%) and less periventricular leukomalacia (4% versus 2%). CONCLUSIONS: A significant increase in the use of NCPAP therapy in the neonatal unit has been associated with a decrease in the use of more invasive therapies. The incidence of BPD has decreased if defined as need for supplemental oxygen at 28 days of age, but not when the 36 weeks' postconceptional age criterion was used. NCPAP therapy may decrease the use of more invasive therapies and may improve respiratory outcomes. The impact of this intervention on nonrespiratory outcomes warrants further investigation.

AB - OBJECTIVE: The aim of the present retrospective study was to describe the use of nasal continuous positive airway pressure (NCPAP) and the prevalence of bronchopulmonary dysplasia (BPD). STUDY DESIGN: Data from 1526 neonates with gestational age less than 32 weeks, admitted to Children's and Women's Health Centre of British Columbia (Vancouver, British Columbia) between period 1 (1996 to 2000) and period 2 (2000 to 2004) were analyzed. The use of respiratory therapies and outcomes were retrospectively compared before and after the introduction of a NCPAP approach to respiratory support. RESULTS: A significant increase in the use of NCPAP was noted between periods 1 and 2 (60% versus 71%), as well as a significant reduction in the use of surfactant (50% versus 41%), postnatal steroids (30% versus 10%) and the need for mechanical ventilation (77% versus 64%). In period 2, there was a significant reduction in the prevalence of BPD at 28 days (33% versus 26%), higher prevalence of severe retinopathy of prematurity (3% versus 6%) and less periventricular leukomalacia (4% versus 2%). CONCLUSIONS: A significant increase in the use of NCPAP therapy in the neonatal unit has been associated with a decrease in the use of more invasive therapies. The incidence of BPD has decreased if defined as need for supplemental oxygen at 28 days of age, but not when the 36 weeks' postconceptional age criterion was used. NCPAP therapy may decrease the use of more invasive therapies and may improve respiratory outcomes. The impact of this intervention on nonrespiratory outcomes warrants further investigation.

KW - Bronchopulmonary dysplasia

KW - CPAP

KW - Neonatology

KW - Premature infants

KW - Retinopathy of prematurity

UR - http://www.scopus.com/inward/record.url?scp=41149150247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149150247&partnerID=8YFLogxK

M3 - Article

C2 - 19183712

AN - SCOPUS:41149150247

VL - 13

SP - 99

EP - 103

JO - Paediatrics and Child Health

JF - Paediatrics and Child Health

SN - 1205-7088

IS - 2

ER -